Unipolar versus Bipolar Depression
On this page
Direct answer
Every "refractory depression" conceals a possible bipolar course until a deliberate screen proves otherwise, because bipolar depression is mislabelled unipolar for years — delays of five to ten years are repeatedly documented. The strongest bipolarity markers are onset before age 25, postpartum onset, a first-degree family history of bipolar disorder, antidepressant-associated hypomania or mania, atypical depressive features (hypersomnia, hyperphagia, leaden paralysis), psychomotor retardation, psychotic features, brief recurrent episodes and repeated antidepressant failures. The Mood Disorder Questionnaire (MDQ) is the standard screening instrument, but the interview question that earns its keep is the retrospective hunt for the "best week of your life". The stakes are pharmacological: antidepressant monotherapy in bipolar depression can trigger switching and cycle acceleration.
What you must remember
- Family and onset clues: onset under 25, bipolar illness in a first-degree relative, postpartum onset, and episodic course with complete inter-episode recovery.
- Pharmacological clue (the strongest): hypomania or mania emerging on an antidepressant — under DSM-5 this CAN count toward bipolar diagnosis if it persists beyond the physiological effect of the drug, a change from DSM-IV rules.
- Phenomenological clues: atypical features (hypersomnia, increased appetite, lethargy), psychomotor retardation, psychotic depression, early-morning mood lability, seasonal pattern.
- Course clue: many short episodes (weeks rather than months), poor or "pooping-out" response to two or more adequate antidepressant trials.
- Screening instruments: MDQ (Mood Disorder Questionnaire) for screening; structured tools such as the SCID or MINI for confirmation; collateral from a relative beats self-report for past hypomania.
- Treatment fork: unipolar depression takes an SSRI; bipolar depression takes quetiapine, lurasidone, cariprazine, olanzapine-fluoxetine or lamotrigine — never an antidepressant alone.
- Ask directly: "Have you ever had four or more days when you felt unusually high, energetic or irritable, needed little sleep, and people noticed?" — a single well-aimed question outperforms vague exploration.
A diagnostic work-through
Sit with a 24-year-old woman labelled "treatment-resistant depression" — three failed SSRIs in two years, each trial adequate in dose and duration. Instead of reaching for a fourth agent, reopen the history. Onset was at 19, within weeks of a delivery (postpartum flag). She sleeps fourteen hours during episodes and eats more (atypical polarity flag). On fluoxetine she cleaned the house for two nights straight and felt "amazing" for six days before crashing — a story of antidepressant-associated hypomania, and by DSM-5 counting, six days of persistent symptoms beyond a transient reaction point toward bipolar spectrum illness rather than mere side-effect.
The examination now has one task: establish whether any spontaneous hypomanic episode occurred — collateral from her mother about a ten-day "super-productive" phase with decreased sleep, increased spending and talkativeness settles it as bipolar II. Management reorients completely: stop chasing antidepressant augmentation, start quetiapine or lamotrigine (given her childbearing plans, lamotrigine with slow titration), psychoeducate about sleep regularity, and warn that future antidepressants must never travel solo. Had the screen been skipped, the fourth SSRI would have been the third mistake.
How the exam frames it
NEET-PG tests this as a vignette-to-diagnosis jump: the option list offers "major depressive disorder, recurrent" versus "bipolar II depression" versus "cyclothymia", and the discriminating sentence hidden in the stem is usually a past period of decreased need for sleep with increased productivity. Remember the duration arithmetic: hypomania needs four days, mania one week (or any duration if hospitalisation is required); cyclothymia means two years of sub-threshold swings with never a full episode. The DSM-5 change on antidepressant-associated hypomania — it may now count — is a modern update examiners have begun quoting against older review books.
Frequently asked questions
Which single historical feature most strongly suggests bipolarity?
Antidepressant-associated hypomania or mania, particularly when symptoms persist beyond the physiological effect of the drug, is among the most predictive clues.
What is the MDQ used for?
The Mood Disorder Questionnaire is a brief self-report screen for a lifetime history of hypomanic or manic symptoms plus associated impairment; a positive screen mandates a diagnostic interview.
Can antidepressants be used alone in bipolar depression?
No — monotherapy risks manic switching and cycle acceleration; agents such as quetiapine, lurasidone, cariprazine or lamotrigine are preferred.
How does DSM-5 treat hypomania caused by an antidepressant?
If symptoms persist beyond the expected physiological effect of the drug, the episode may be counted toward a bipolar diagnosis — a deliberate departure from DSM-IV.
How do you distinguish bipolar II depression from cyclothymia?
Bipolar II requires full hypomanic and major depressive episodes, whereas cyclothymia involves at least two years of subsyndromal highs and lows that never meet full episode criteria.